Tumour markers

肿瘤标志物
  • 文章类型: Systematic Review
    结直肠癌(CRC)筛查可有效降低CRC相关死亡率。当前的筛选方法包括基于内窥镜的方法和基于生物标志物的方法。本指南是亚太胃肠病学协会(APAGE)和亚太消化内镜学会(APSDE)的联合官方声明。为响应越来越多的使用而开发的,积累起作用的支持性证据,用于诊断CRC及其前体病变的非侵入性生物标志物。对678种出版物进行了系统审查,并进行了两个阶段的德尔菲共识过程,涉及各学科的16名临床医生,以制定32种基于证据和专家意见的粪便免疫化学测试建议。基于粪便的肿瘤生物标志物或微生物生物标志物,和基于血液的肿瘤生物标志物用于检测CRC和腺瘤。提供了关于适应症的全面最新指导,患者选择以及每种筛查工具的优势和局限性。与研究重点的客观测量一起讨论了为临床应用提供信息的未来研究。本APAGE-APSDE联合实践指南旨在提供最新指南,以帮助全球临床医生利用非侵入性生物标志物进行CRC筛查;它对亚太地区的临床医生特别重要。
    Screening for colorectal cancer (CRC) is effective in reducing CRC related mortality. Current screening methods include endoscopy based and biomarker based approaches. This guideline is a joint official statement of the Asian Pacific Association of Gastroenterology (APAGE) and the Asian Pacific Society of Digestive Endoscopy (APSDE), developed in response to the increasing use of, and accumulating supportive evidence for the role of, non-invasive biomarkers for the diagnosis of CRC and its precursor lesions. A systematic review of 678 publications and a two stage Delphi consensus process involving 16 clinicians in various disciplines was undertaken to develop 32 evidence based and expert opinion based recommendations for the use of faecal immunochemical tests, faecal based tumour biomarkers or microbial biomarkers, and blood based tumour biomarkers for the detection of CRC and adenoma. Comprehensive up-to-date guidance is provided on indications, patient selection and strengths and limitations of each screening tool. Future research to inform clinical applications are discussed alongside objective measurement of research priorities. This joint APAGE-APSDE practice guideline is intended to provide an up-to-date guide to assist clinicians worldwide in utilising non-invasive biomarkers for CRC screening; it has particular salience for clinicians in the Asia-Pacific region.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    背景:肿瘤标志物(TM)的不适当使用是一个常见问题。此审核的目的是评估当地指南对普外科部门TM请求模式的影响。
    方法:CA125,CA19-9,CA15-3,CEA,在实施本地请求指南之前和之后的两个八个月中,对所有医院手术地点的AFP和HCG请求进行了审核。
    结果:干预后,总TM请求减少了32%,而患者请求减少了9.8%。单个TM请求增加,对包含四个或更多TM的面板的请求从279个减少到60个请求(减少78%)。
    结论:部门间的合作和当地指南的实施导致了请求行为的变化,最值得注意的是多个TM面板请求的减少。
    BACKGROUND: The inappropriate use of tumour markers (TMs) is a common problem. The aim of this audit was to evaluate the impact of local guidelines on the TM requesting patterns of a General Surgery Department.
    METHODS: CA 125, CA 19-9, CA15-3, CEA, AFP and HCG requests from all hospital surgical locations were audited over two periods of eight months before and after the implementation of local requesting guidelines.
    RESULTS: Postintervention, total TM requests decreased by 32% while patient requests decreased by 9.8%. Single TM requesting increased and requests for panels containing four or more TMs decreased from 279 to 60 requests (78% reduction).
    CONCLUSIONS: Interdepartmental collaboration and the implementation of local guidelines have resulted in a change in requesting behaviour, most notably a reduction in multiple TM panel requests.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

公众号